Recurrence in patients with stage I colorectal cancer

ANZ Journal of Surgery

Volumn 86, Issue 1-2, 2016, Pages 49-53

  Teloken, Patrick Ely ^a   Ransom, David ^a   Faragher, Ian ^b   Jones, Ian ^c   Gibbs, Peter ^c   Platell, Cameron ^d,e  

^a ROYAL PERTH HOSPITAL   (Australia)

^b WESTERN HEALTH   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d ST JOHN OF GOD HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Colon cancer; Rectal cancer; Recurrence; Surveillance

Indexed keywords

AGED; CANCER STAGING; COLORECTAL NEOPLASMS; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECTAL NEOPLASMS; RISK FACTOR; SURVIVAL ANALYSIS; TUMOR RECURRENCE; VICTORIA;

AGED; COLORECTAL NEOPLASMS; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; VICTORIA;

EID: 84958775816     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.13254     Document Type: Article

References (31)

1. AIHW & AACR 2012. Cancer in Australia: an overview 2012. Cancer series no. 74. Cat. no. CAN 70. Canberra: AIHW.
2. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005.
3. National Comprehensive Cancer Network. Colon cancer v3 [Internet]. Clinical Practice Guidelines in Oncology. 2014 [Cited 18 Jul 2014.] Available from URL: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
4. National Comprehensive Cancer Network. Rectal cancer v3 [Internet]. Clinical Practice Guidelines in Oncology. 2014 [Cited 18 Jul 2014.] Available from URL: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
5. Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013; 24 (Suppl. 6): vi81-88.
6. Labianca R, Nordlinger B, Beretta GD etal. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013; 24 (Suppl. 6): vi64-72.
7. Meyerhardt JA, Mangu PB, Flynn PJ etal. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J. Clin. Oncol. 2013; 31: 4465-4470.
8. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (eds). AJCC Cancer staging manual, 7th edn. New York: Springer, 2010.
9. Kosmider S, Jones I, Hibbert M etal. Towards establishing a national colorectal cancer database: lessons learnt from Bio21 molecular medicine informatics model. ANZ J. Surg. 2008; 78: 803-809.
10. Hosmer DW, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time to Event Data, 2nd edn. Hoboken: Wiley, 2008.
11. Blumberg D, Stage I. Rectal cancer: identification of high-risk patients. J. Am. Coll. Surg. 1998; 186: 574-580.
12. Iida S, Hasegawa H, Okabayashi K, Moritani K, Mukai M, Kitagawa Y. Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer. World J. Surg. 2012; 36: 424-430.
13. Keum MA, Lim S-B, Kim SA etal. Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer. J. Korean Soc. Coloproctol. 2012; 28: 49-55.
14. Kim SH, Bae KB, Kim JM etal. Oncologic outcomes and risk factors for recurrence after tumor-specific mesorectal excision of rectal cancer: 782 Cases. J. Korean Soc. Coloproctol. 2012; 28: 100-107.
15. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann. Surg. 2004; 240: 260-268.
16. Sticca RP, Rodriguez-Bigas M, Penetrante RB, Petrelli NJ. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996; 14: 491-497.
17. Wichmann MW, Müller C, Hornung HM, Lau-Werner U, Schildberg F-W, Colorectal Cancer Study Group. Results of long-term follow-up after curative resection of Dukes a colorectal cancer. World J. Surg. 2002; 26: 732-736.
18. Willett CG, Lewandrowski K, Donnelly S etal. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992; 69: 1651-1655.
19. Mroczkowski P, Schmidt U, Sahm M, Gastinger I, Lippert H, Kube R. Prognostic factors assessed for 15, 096 patients with colon cancer in stages I and II. World J. Surg. 2012; 36: 1693-1698.
20. Elferink MA, Visser O, Wiggers T etal. Prognostic factors for locoregional recurrences in colon cancer. Ann. Surg. Oncol. 2012; 19: 2203-2211.
21. Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J. Surg. 2007; 31: 1485-1490.
22. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J. Mol. Diagn. 2007; 9: 563-571.
23. Sirop S, Kanaan M, Korant A etal. Detection and prognostic impact of micrometastasis in colorectal cancer. J. Surg. Oncol. 2011; 103: 534-537.
24. Bilchik A, Nissan A, Wainberg Z etal. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann. Surg. 2010; 252: 467-474, discussion 474-6.
25. Teloken PE, Spilsbury K, Levitt M etal. Outcomes in patients undergoing urgent colorectal surgery. ANZ J. Surg. 2014; 84: 960-964.
26. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis. Colon Rectum 2007; 50: 1783-1799.
27. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst. Rev. 2007; (1): CD002200.
28. Figueredo A, Rumble RB, Maroun J etal. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3: 26.
29. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813.
30. Primrose JN, Perera R, Gray A etal. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014; 311: 263-270.
31. Tsikitis VL, Malireddy K, Green EA etal. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J. Clin. Oncol. 2009 ; 27: 3671-3676.